Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma, Head And Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06446570
What this trial is testing

Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma

Who this might be right for
HNSCCHead and Neck Neoplasms
Seoul National University Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT02901483
What this trial is testing

PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
PharmaEngine 12
Not applicableActive Not RecruitingNCT05934929
What this trial is testing

Contribution of Residual Tumour DNA Testing on the Surgical Bed

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity
Centre Henri Becquerel 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT07374003
What this trial is testing

Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced, Resectable
Sun Yat-sen University 62
Not applicableStudy completedNCT07363629
What this trial is testing

Impact of Preserving Versus Ligating the Right Gastric Artery on Anastomotic Outcomes After McKeown Esophagectomy: A Randomized Controlled Trial

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Hospital of Hebei Medical University 120
Testing effectiveness (Phase 2)Study completedNCT04856631
What this trial is testing

Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Squamous Cell Cancer
Shanghai Junshi Bioscience Co., Ltd. 88
Not applicableStudy completedNCT06063941
What this trial is testing

High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Xijing Hospital of Digestive Diseases 450
Testing effectiveness (Phase 2)Study completedNCT03735680
What this trial is testing

Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaColorectal Cancer+4 more
OncoNano Medicine, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT00646659
What this trial is testing

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 47
Early research (Phase 1)Ended earlyNCT01975688
What this trial is testing

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

Who this might be right for
Head and Neck Squamous Cell Carcinoma
GW Pharmaceuticals Ltd 10
Not applicableEnded earlyNCT00898742
What this trial is testing

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 58
Not applicableStudy completedNCT05821179
What this trial is testing

Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma
Fayoum University 36
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)Ended earlyNCT05904496
What this trial is testing

BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
BeiGene 44
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07062354
What this trial is testing

Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head &Amp; Neck CancerHead &Amp; Neck Squamous Cell Carcinoma
SWOG Cancer Research Network 50
Not applicableLooking for participantsNCT04534127
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 56
Not applicableUnknownNCT05024383
What this trial is testing

Dissecting the Heterogeneity of Oral Cancer Pain

Who this might be right for
Oral Squamous Cell Carcinoma
NYU College of Dentistry 80
Testing effectiveness (Phase 2)Study completedNCT04868162
What this trial is testing

Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Lepu Biopharma Co., Ltd. 70
Testing effectiveness (Phase 2)Looking for participantsNCT06323369
What this trial is testing

Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 154
Testing effectiveness (Phase 2)Ended earlyNCT04936841
What this trial is testing

Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
University of Wisconsin, Madison 5
Next Page